Schedule regular follow-ups to track progress, address side effects, and check results
GLP2 versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): A randomised, open-label, parallel-group, multicentre, phase 3 trial
B12 & Lipotropic injections 2x/month included, $20 excess Tirzepatide 10mg-12.5mg $6,250/year PrePaid $ 1,875 /quarter EKG and spirometry included if needed follow-up labs as needed 1st one free (14 days) Weight, BMI, Body Fat, Fat-free body weight, subcutaneous fat, visceral fat, body water, skeletal muscle, Muscle Mass, Bone mass, Protein, BMR, Body age, Fat mass, Water weighyt, Protein mass, Obesity level, Body type e.g
doi: 10.1523/JNEUROSCI.1865-19.2020 85 CarboneFVerschuerenSRotondoATackJ
doi: 10.1002/dmrr.1080 134 GersteinHCColhounHMDagenaisGRDiazRLakshmananMPaisPet al
Rather than applying uniform treatment protocols, were moving toward precision medicine that considers each patients unique metabolic fingerprint
.png)
